knowledge -WSS

knowledge

author：fashion 2025-10-01 00:05:30 - browse：469

A doctor climbs up a red ladder to a vine shaped like a DNA — biotech coverage from STAT — Adobe

Every morning, Victoria Rasberry gets up before 6 a.m., walks to the bedroom down the hall, and helps her 8-year-old daughter Addi slide into a set of contraptions that squeeze and suck out the thick mucus constantly threatening to choke her airways closed. She feeds Addi breakfast through a stomach tube and makes sure she has the right mix of the 28 different medications required to keep her free of pain, infections, and seizures. At some point, Rasberry’s five other children will wake up and start to get ready for school, including her youngest, Oliver. At 3-and-a-half years old, he’s a typical toddler — always running and giggling and getting into things. You would never know that he and Addi were born with the same mutation lurking in their DNA, a genetic glitch that causes a fatal neurodegenerative disease called metachromatic leukodystrophy, or MLD.

“When Addi was this age she had lost the ability to speak and was already using a ventilator to sleep at night,” Rasberry said. “It’s amazing to see how well Ollie is doing in comparison. And it’s all because of the gene therapy.”

Three years ago, when Ollie was just 6 months old, he and Victoria traveled from their home in Texas to Milan, to receive a gene therapy treatment that adds a healthy version of the defective gene into patients’ own stem cells. At the time, traveling abroad for the therapy, which is manufactured by Orchard Therapeutics and was approved in Europe in 2021, was the only option for families stricken by MLD. But soon it will be available in the U.S., too.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Do masks work? RCTs can't tell us

WSS

The battle over the Brookhaven Landfill on Long Island

Why are elite athletes different? Take a look at their microbes

Inaction leaves children at risk from dangerous chemotherapy drug

Why drug prescriptions should include diagnoses

FDA endorses new sterilization method for medical devices

Paxlovid study fails to answer questions over benefit for broader groups

hotspot

knowledge

leisure time

Apple is now the first public company to be valued at $3 trillion

There's an unseen cost to disruptive road

Guidelines to prevent youth baseball injuries need more muscle

WATCH: Why do fingernails fall off when they're damaged?

After affirmative action ruling, medical educators look to 'holistic review'

To bolster infectious disease surveillance, genomics powerhouses team up

After affirmative action ruling, medical educators look to 'holistic review'

Future doctors need a strong humanities education

Cancer drug shortages should be causing more outrage

Maisha Meds is a PBM, but don't call it that

leisure time

Paxlovid study fails to answer questions over benefit for broader groups

What is the Wagner Group? The 'brutal' Russian military unit in Ukraine

What would happen to your eyes if you looked at the solar eclipse?

Medicare bonuses could stop drug shortages under Senate plan

Mass General, Mayo Clinic look to monetize custom

Prior authorization reform is both possible and imperative

entertainment

leisure time

entertainment

entertainment